解开TNBC基因相互作用网络的复杂性
Priyanga Paranthaman1, HemaNandini Rajendran Krishnamoorthy1, Selvakumar Veluchamy2
1Department of Biotechnology, School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
三重阴性乳腺癌 (TNBC) 是一种侵袭性疾病. 网络分析发现EP300是关键蛋白质,从而发现了提尔巴尼布林作为一种潜在的药物候选物,用于对抗TNBC.
科学领域:
- 癌症学
- 生物信息学
- 计算生物学
背景情况:
- 三重阴性乳腺癌 (TNBC) 是一种具有有限向治疗的侵袭性亚型.
- 基于蛋白质与蛋白质相互作用的网络分析 (PPI) 可以确定癌症中的关键调节蛋白.
研究的目的:
- 使用PPI网络分析识别TNBC中的枢纽蛋白.
- 通过药物重新定位来发现EP300的潜在药物候选物,这是TNBC的关键蛋白.
主要方法:
- 在TNBC中构建了1413个失调基因的PPI网络.
- 包括TP53,SRC,EP300,AKT1,HSP90AA1,MAPK3,EGFR和SMAD3在内的已识别的中心蛋白.
- 使用分子对接,MM-GBSA和基于ML的再评分来选FDA批准的化合物与EP300,识别提巴尼布林 (DB06137).
主要成果:
- 在PPI网络中发现了枢纽基因之间的显著相互作用.
- 没有FDA批准的药物直接针对EP300蛋白.
- 提尔巴尼布林 (DB06137) 与EP300具有强烈的结合亲和力和结构稳定性,这表明其具有治疗潜力.
结论:
- 提尔巴尼布林是一种有前途的药物候选物,用于针对TNBC的EP300.
- 需要进一步的实验验证,以探索提巴尼布林对EP300的疗效和机制.
- 这项研究突显了网络分析和药物重定向在推进TNBC治疗方面的潜力.
更多相关视频
07:42Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
相关概念视频
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Gene Therapy
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Targeted Cancer Therapies
There are several types of targeted therapies against...
Microorganisms in Medicine and Therapeutics
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
